Compounding pharmacies in Nevada
By the PeptideAgent Editorial Team. Draft, pending editorial review. Last verified
The Nevada State Board of Pharmacy regulates compounding pharmacies in Nevada. Compounded GLP-1 limited. How to check a pharmacy's license, plus verified listings.
Nevada at a glance
- Pharmacy regulator
- Nevada State Board of Pharmacy
- 503A framework
- Follows the federal 503A framework
- Telehealth prescribing
- Regulatory: Telehealth allowed
- Asynchronous prescribing
- Regulatory: Async allowed
- Compounded GLP-1 access
- Regulatory: Compounded GLP-1 limited
Verified compounding pharmacies serving Nevada
No verified compounding pharmacies serving Nevada are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.
Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.
Run a pharmacy, clinic, or telehealth service? Apply for a listing.
Who regulates compounding pharmacies in Nevada
The Nevada State Board of Pharmacy licenses pharmacists, pharmacies, and out-of-state pharmacies under NRS chapter 639 and adopts rules in NAC chapter 639. NRS 639.2328 provides that every pharmacy located outside Nevada that dispenses prescriptions to patients located in Nevada must be licensed by the Board, and to be licensed it must hold a pharmacy license in its home state, comply with applicable federal law, and name a responsible pharmacist. The Board's compounding rules are in NAC 639.661 to 639.690 (compounding and dispensing drug products): NAC 639.670 adopts the 2023 United States Pharmacopeia and National Formulary by reference, and NAC 639.67053 requires every pharmacist and technician who compounds sterile products to comply with USP chapter 797. Nevada has no state bulks list; peptide eligibility follows the federal 503A framework. [1] [4] [5] [6] [8]
Compounded GLP-1 access in Nevada
Nevada's broad telehealth definition makes app-based GLP-1 programs lawful on the prescribing side if the prescriber holds a Nevada license, and the dispensing pharmacy must be licensed by the Nevada State Board of Pharmacy. [1] [2] [11]
Research use only sellers in Nevada
Nevada's food and drug law (NRS chapter 585) prohibits selling adulterated or misbranded drugs, and NRS chapter 639 restricts dispensing of prescription drugs to licensed pharmacies and practitioners. [3] [7] [12]
Nevada notes on specific peptides
- Semaglutide: Available branded by prescription, including from a Nevada-licensed telehealth prescriber using synchronous or asynchronous telehealth under NRS 629.515. Compounded semaglutide is limited to the federal patient specific exception since April 22, 2025. [2] [11]
How to check a compounding pharmacy in Nevada
- Search the Nevada State Board of Pharmacy license lookup for the pharmacy by name. A pharmacy based elsewhere needs whatever license or registration Nevada requires before it ships to you. [1] [4] [5] [6] [8]
- Ask whether it operates as a 503A pharmacy or a 503B outsourcing facility, and confirm a 503B claim against FDA's outsourcing facility information (see the verification checklist).
- Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
- Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Nevada. [3] [7] [12]
Common questions in Nevada
Can an out-of-state pharmacy ship compounded peptides to me in Nevada?
Only if it is licensed by the Nevada State Board of Pharmacy. Search the Board's license verification before ordering. [1] [4]
Can a Nevada pharmacy compound BPC-157?
No, not from bulk today. BPC-157 is not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk. State boards cannot authorize what federal law does not. Peptides still in FDA Category 2 cannot be compounded either. [8] [9] [10]
Sources
- [1]Nevada State Board of Pharmacy
- [2]NRS 629.515, Telehealth: license required; establishment of relationship with patient
- [3]NRS chapter 639, Pharmacy
- [4]NRS 639.2328, Pharmacy located outside Nevada that dispenses prescriptions to patients located in Nevada: licensing
- [5]NAC 639.67053, Compounding standards (sterile compounded drug products, USP chapter 797)
- [6]NAC chapter 639, Pharmacy
- [7]NRS chapter 585, Food, drugs and cosmetics
- [8]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
- [9]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
- [10]FDA: Pharmacy Compounding Advisory CommitteeFDA
- [11]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
- [12]21 U.S.C. 331, Prohibited acts